文献速递创伤与烧伤重症综合管理与镇静镇痛

创伤后静脉血栓栓塞患者的循环核小体升高:一项前瞻性病例队列研究

Circulating Nucleosomes are Elevated in Trauma Patients with Venous Thromboembolism: A Prospective Case-Cohort Study.
PubMed 文献 · Shock · 2026-03-16
一句话结论创伤后12小时内循环核小体H3.1与H3R8 Cit升高,发生VTE者升高更明显,中位VTE时间为8.5天。

该前瞻性病例队列研究在I级创伤中心纳入639例创伤患者,伤后12小时内采集枸橼酸化血样,随访90天,以影像或尸检确认VTE,按1:3选取VTE者160例与无VTE者479例比较。创伤患者H3.1和H3R8 Cit水平均高于10名健康志愿者(P<0.001)。发生VTE者H3.1为828.4 ng/mL、H3R8 Cit为350.4 ng/mL,分别高于无VTE者的276.7 ng/mL和189.2 ng/mL(P<0.001和P=0.005)。VTE患者中位VTE时间为8.5天,早期与晚期VTE之间核小体水平无差异。

要点

  • 创伤患者伤后12小时内H3.1为359.7 ng/mL、H3R8 Cit为209.4 ng/mL,均高于10名健康志愿者的21.5 ng/mL和22.3 ng/mL(P<0.001)。
  • 发生VTE的160例创伤患者H3.1为828.4 ng/mL,高于无VTE的479例的276.7 ng/mL(P<0.001)。
  • 发生VTE者H3R8 Cit为350.4 ng/mL,高于无VTE者的189.2 ng/mL(P=0.005)。
  • VTE患者中位VTE时间为8.5天,其中深静脉血栓91例、肺栓塞48例、两者兼有21例。
  • 早期(伤后0-7天诊断)与晚期(>7天诊断)VTE之间H3.1和H3R8 Cit水平无差异。

适用人群与场景

  • 就诊于I级创伤中心的创伤患者,伤后12小时内采集枸橼酸化血样。
  • VTE组与无VTE组按1:3比例选取,最终比较160例VTE患者与479例无VTE患者。
  • 创伤患者总体特征:年龄51岁(33,65),男性71.0%,钝性伤94.1%,损伤严重度评分17(9,27)。

诊断标准与关键阈值

  • VTE发生经尸检或影像学确认。
  • VTE定义为发生症状性VTE。
  • 早期VTE为伤后0-7天诊断,晚期VTE为伤后>7天诊断。

研究设计与关键结果

  • 研究类型:前瞻性病例队列研究,纳入639例创伤患者,随访至90天。
  • 创伤患者H3.1为359.7(58.4,1769.3)ng/mL,高于10名健康志愿者的21.5(15.3,26.6)ng/mL,P<0.001。
  • 创伤患者H3R8 Cit为209.4(45.4,665.5)ng/mL,高于健康志愿者的22.3(16.2,28.9)ng/mL,P<0.001。
  • VTE患者H3.1为828.4(112.0,3186.5)ng/mL,高于无VTE患者的276.7(50.3,1237.0)ng/mL,P<0.001。
  • VTE患者H3R8 Cit为350.4(77.4,729.5)ng/mL,高于无VTE患者的189.2(40.8,632.6)ng/mL,P=0.005。
  • VTE患者中位VTE时间为8.5天,其中症状性深静脉血栓91例、肺栓塞48例、深静脉血栓合并肺栓塞21例。
  • VTE组与无VTE组年龄、性别、致伤机制无显著差异;VTE组损伤严重度评分更高[24(14,34)vs 14(9,24),P<0.001],体重指数更高[29.1(24.3,34.2)vs 27.6(24.2,32.0)kg/m²,P=0.037]。
  • VTE组接受全身麻醉手术比例更高(53.1% vs 34.0%,P<0.001),伤后24小时内接受输血比例更高(51.9% vs 24.0%,P<0.001)。

证据类型、等级与局限

  • 证据类型:前瞻性病例队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,这些发现强调理解核小体诱导VTE的病理生理及其作为生物标志物的作用的重要性。
  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: The identification of reliable biomarkers in trauma patients (pts) remains a clinical challenge. Nucleosomes, which are DNA wrapped around histone protein cores, have been used as reliable markers for quantification in sepsis, acute respiratory distress syndrome, and lymphoma. We hypothesized that: 1) levels of circulating nucleosomes quantified after traumatic injury, specifically histone H3.1 and its citrullinated R8 posttranslation modification (H3R8 Cit), would be increased after trauma and 2) that levels of circulating nucleosomes would be further, increased in pts who went on to develop venous thromboembolism (VTE), as these nucleosomes may be clot-enhancing mediators.

METHODS: Trauma pts presenting to a Level I trauma center were evaluated for inclusion in a prospective case-cohort study, and citrated blood samples were collected within 12 hours of injury. Pts were followed for up to 90 days and VTE occurrence was confirmed via autopsy or imaging. Pts who developed incident, symptomatic VTE, and those who did not develop VTE were selected at a 1:3 ratio. The effect of trauma was assessed by comparison with healthy volunteer samples. Circulating nucleosomes were quantified using Nu.Q H3.1 and Nu.Q H3R8 Cit assays. Data are presented as median [interquartile range] or n (%), with Wilcoxon Rank-Sum or chi-squared test performed between trauma pts who developed symptomatic VTE versus those who did not, with a P value < 0.05 as statistically significant.

RESULTS: A total of 639 trauma pts were analyzed [51 years (33, 65), 71.0% male, 94.1% blunt, injury severity scores 17 (9, 27)]. Both H3.1 [359.7 (58.4, 1769.3) vs. 21.5 (15.3, 26.6) ng/mL, P < 0.001] and H3R8 Cit levels [209.4 (45.4, 665.5) vs. 22.3 (16.2, 28.9) ng/mL, P < 0.001] were greater in trauma pts than in 10 healthy volunteers. The 160 pts with VTE were then compared with 479 without VTE. VTE pts had a median time to VTE of 8.5 days, with 91 developing symptomatic deep venous thrombosis, 48 with pulmonary embolism, and 21 with both deep venous thrombosis and pulmonary embolism. No significant differences were found in age, sex, or mechanism between pts with or without VTE. However, VTE pts had higher injury severity scores [24 (14, 34), 14 (9, 24), P < 0.001] and body mass index [29.1 (24.3, 34.2), 27.6 (24.2, 32.0) kg/m 2 , P = 0.037]. A greater percentage of VTE pts underwent surgery requiring general anesthesia (53.1%, 34.0%, P < 0.001) and received blood transfusions within 24 hours of injury (51.9%, 24.0%, P < 0.001). H3.1 levels were significantly greater in trauma pts who developed VTE compared with those who did not [828.4 (112.0, 3186.5), vs. 276.7 (50.3, 1237.0) ng/mL, P < 0.001], as were H3R8 Cit levels [350.4 (77.4, 729.5), vs. 189.2 (40.8, 632.6) ng/mL, P = 0.005]. No differences in levels of H3.1 and H3R8 Cit were found between early (diagnosed day 0-7 after injury) and late (diagnosed > day 7) VTE.

CONCLUSIONS: Levels of the H3.1 and H3R8 Cit nucleosomes are elevated early after traumatic injury, especially in those who developed VTE. These findings underscore the importance of understanding the pathophysiology of nucleosomes in inducing VTE and their role as biomarkers.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Navarro SM, Thompson RJ, Spears GM, et al. Circulating Nucleosomes are Elevated in Trauma Patients with Venous Thromboembolism: A Prospective Case-Cohort Study. Shock. 2026. PMID: 41886536. doi:10.1097/SHK.0000000000002807

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。